title: When to Use Prophylactic Antibiotics in Neutropenic Patients.
authors.forename: Andrea
authors.initials: A
authors.lastname: Zimmer
authors.forename: Alison
authors.initials: A
authors.lastname: Freifeld
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000276:immunology / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D016867:Immunocompromised Host; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D009894:Opportunistic Infections / Q000276:immunology / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents